Vorinostat Completed Phase 1 Trials for Non-Small Cell Lung Carcinoma (NSCLC) Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT00731952Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer